Dr. Carlos Acosta

DDS | Dentist



  
  165 Sherman Ave, 5d, New York
  New York, 10034-4602

  718-584-3826    718-584-7309 Maps & Directions
Dr. Carlos Acosta is a New York, New York based Dentist who is specialized in Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 165 Sherman Ave, 5d, New York. Patients can reach him at 718-584-3826.
Dr. Carlos Acosta is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Carlos Acosta speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Carlos Acosta
Specialization: Dentist
Gender:Male
Credentials: DDS
Accepts Medicare Assignment:May Accept
Practice Address:165 Sherman Ave, 5d, New York,
New York, 10034-4602
Phone:718-584-3826
Fax:718-584-7309
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 8123386380
Enrollment ID: I20171215000669
NPI Number: 1831412865
NPI Enumeration Date: 04 Mar, 2010
NPI Last Update On: 04 Mar, 2010

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 165 Sherman Ave, 5d
New York, New York
Zip: 10034-4602
Phone Number: 718-584-3826
Fax Number: 718-584-7309
Patients can reach Dr. Carlos Acosta at 165 Sherman Ave, 5d, New York, New York or can call to book an appointment on 718-584-3826. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.

Comments/ Reviews: